Not Evaluated by the FDA: This product has not been evaluated by the Food and Drug Administration (FDA)
Most people who read this far now understand why stacking BPC-157, TB-500, and GHK-Cu without first stabilizing the healing environment often leads to slower or incomplete results
Health Risks and Safety Concerns for Women While the appeal of BPC-157 and TB-500 lies in their potential for faster recovery and reduced inflammation, the risks for women are significant and largely unknown
Individuals with known hypersensitivity to ascorbic acid, those with a history of oxalate kidney stones, G6PD deficiency, iron overload disorders, or severe renal impairment should avoid this product
Register Now Browse upcoming training dates and register for hands-on workshops in San Diego, CA
Staresinic M, Petrovic I, Novinscak T, Jukic I, Pevec D